[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-564735-105":53,"doc-detail-564735-en":124},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":117,"head_meta":119,"extra_data":121,"updated_unix":123},105,"en","mercy-managed-behavioral-health-adhd-medication-guideline-2012","Mercy Managed Behavioral Health ADHD Medication Guideline - 2012","","Mercy Managed Behavioral Health provides an ADHD medication guideline from 2012 with medication-by-medication charts covering dosing, expected time to effect, duration of effect, common side effects, practical pros, and key precautions. It compares first-line methylphenidate formulations (short, mid, and long acting) and their typical onset and wearing-off patterns, including abuse and rebound considerations. It also outlines amphetamine options with dosing guidance by age and highlights safety cautions such as insomnia, appetite and weight effects, and misuse-related risks.",{"@graph":63,"@context":116},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/mercy-managed-behavioral-health-adhd-medication-guideline-2012/564735/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/mercy-managed-behavioral-health-adhd-medication-guideline-2012/564735.png","ImageObject",442,249,{"name":88,"@type":89},"GGG","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-25","2026-10-12",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",6,{"@type":103,"mainEntity":104},"FAQPage",[105,110,113],{"name":106,"@type":107,"acceptedAnswer":108},"What dosing approach does the guideline recommend for short-acting methylphenidate in children?","Question",{"text":60,"@type":109},"Answer",{"name":111,"@type":107,"acceptedAnswer":112},"What are common side effects and rebound-related concerns mentioned for stimulant medications?",{"text":60,"@type":109},{"name":114,"@type":107,"acceptedAnswer":115},"What precautions does the guideline emphasize before using methylphenidate formulations?",{"text":60,"@type":109},"https://schema.org",{"og:url":78,"og:type":118,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":120,"canonical":78},"index,follow",{"doc_id":122,"site_id":56},564735,1792097054,{"code":4,"msg":5,"data":125},{"doc_id":122,"user_id":126,"nickname":88,"user_avatar":127,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":128,"file_id":129,"file_url":130,"file_type":131,"file_size":132,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":47,"language":133,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":134,"faqs":135,"seo_title":136,"seo_description":61,"update_tm":137,"read_time":73},962093532725,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Mercy Managed Behavioral Health ADHD Medication Guideline: 2012  \n\n| Medication Chart to Treat Attention Deficit Hyperactivity Disorder (ADHD) |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- |\n| DRUG | FORM | DOSING | COMMON SIDE EFFECTS | DURATION OF EFFECTS | PROS | PRECAUTIONS |\n| FIRST LINE |  |  |  |  |  |  |\n| METHYLPHENIDATE |  |  |  |  |  |  |\n| RITALIN\u003Cbr>METHYLIN\u003Cbr>METADATE\u003Cbr>Generic MPH | Short Acting\u003Cbr>Tablet \u003Cbr>5 mg\u003Cbr>10 mg\u003Cbr>20 mg | Starting dose for children is 5 mg twice daily, 3-4 hours apart. Add third dose about 4 hours after second. Adjust timing based on duration of action. Increase by 5-10 mg increments. Daily dosage above 60 mg not recommended. Estimated dose range .3-.6 mg/kg/dose | Insomnia, decreased appetite, weight loss, headache, irritability, stomachache, and rebound agitation or exaggeration of pre-medication symptoms as it is wearing off. | About 3-4 hours. Most helpful when need rapid onset and short duration. | Works quickly (within\u003Cbr>30-60 minutes) .\u003Cbr>Effective in over 70%\u003Cbr>of patients. | Use cautiously in patients with marked anxiety, motor tics or with family history of Tourette syndrome, or history of substance abuse or history of cardiac disease. Don't use if glaucoma or on MAOI. |\n| FOCALIN (with isolated dextroisomer) FOCALIN XR ( .5 immed, .5 delayed) | Short Acting\u003Cbr>Tablet\u003Cbr>2.5 mg\u003Cbr>5mg\u003Cbr>10mg\u003Cbr>15mg, 20mg\u003Cbr>30mg, 40mg | Start with half the dose recommended for normal short acting mehtylphenidate above. Dose may be adjusted in 2.5 to\u003Cbr>5 mg increments to a maximum of 20 mg per day (10 mg twice daily) . | As above.\u003Cbr>There is suggestion that Focalin (dextro-isomer) maybe less prone to causing sleep or appetite disturbance. | About 3-4 hours. Most helpful when need rapid onset and short duration. Only formulation with isolated dextro-isomer. | Works quickly (within\u003Cbr>30-60 minutes) .\u003Cbr>Possibly better for use\u003Cbr>for evening needs\u003Cbr>when day's long acting\u003Cbr>dose is wearing off.\u003Cbr>May sprinkle etc | As above.\u003Cbr>Expensive compared to\u003Cbr>other short acting\u003Cbr>preparations. |\n| RITALIN SR\u003Cbr>METHYLIN ER\u003Cbr>METADATE ER | Mid Acting\u003Cbr>Tablet\u003Cbr>20mg\u003Cbr>Mid Acting\u003Cbr>Tablet\u003Cbr>10mg\u003Cbr>20mg | Start with 20 mg daily. May combine with short acting for quicker onset and/or coverage after this wears off. | Insomnia, decreased\u003Cbr>appetite, weight loss,\u003Cbr>headache, irritability,\u003Cbr>stomachache. | Onset delayed for 60-90 minutes. Duration supposed to be 6-8 hours, but can be quite individual and unreliable. | Wears off more\u003Cbr>gradually than short\u003Cbr>acting so less risk of\u003Cbr>rebound. Lower abuse\u003Cbr>risk. | As above.\u003Cbr>Note: If crushed or cut, full dose may be released at once, giving twice the intended dose in first 4 hours, none in the second 4 hours. |\n| RITALIN LA\u003Cbr>50% immediate release beads\u003Cbr>and 50% delayed release beads\u003Cbr>METADATE CD 30% immediate release and 70% delayed release beads | Mid Acting\u003Cbr>Capsule \u003Cbr>20 mg\u003Cbr>30mg\u003Cbr>40mg\u003Cbr>Mid Acting\u003Cbr>Capsule\u003Cbr>10 mg\u003Cbr>20 mg\u003Cbr>30mg | Starting dose is 10-20 mg once daily. May be adjusted weekly in 10 mg increments to maximum of 60 mg taken once daily. May add short acting dose in AM or 8 hours later in PM if needed. | Insomnia, decreased appetite, weight loss, headache, irritability, stomachache, and rebound potential. | Onset in 30-60 minutes.\u003Cbr>Duration about 8 hours. | May swallow whole or\u003Cbr>sprinkle ALL contents\u003Cbr>on a spoonful of\u003Cbr>applesauce. Starts\u003Cbr>quickly, avoids mid\u003Cbr>day gap unless\u003Cbr>student metabolizes\u003Cbr>medicine very rapidly. | Same cautions as for immediate release.\u003Cbr>If beads are chewed, may release full dose at once, giving entire contents in first\u003Cbr>4 hours. |\n\nSource: MyADHD.com at: [http://www.myadhd.com/treatment_tools/medicationchart.html](http://www.myadhd.com/treatment_tools/medicationchart.html) 1  \nMercy Managed Behavioral Health ADHD Medication Guideline: 2012  \n\n| CONCERTA\u003Cbr>22% immediate release and 78% gradual release | Long Acting\u003Cbr>Tablet \u003Cbr>18 mg\u003Cbr>2","cbCailld9Soh6E7V","https://ap.wps.com/l/cbCailld9Soh6E7V","pdf",56019,"English","# ADHD Medication Guideline\n## Medication charts and dosing details","[{\"question\":\"What dosing approach does the guideline recommend for short-acting methylphenidate in children?\",\"answer\":\"\"},{\"question\":\"What are common side effects and rebound-related concerns mentioned for stimulant medications?\",\"answer\":\"\"},{\"question\":\"What precautions does the guideline emphasize before using methylphenidate formulations?\",\"answer\":\"\"}]","Mercy Managed Behavioral Health ADHD Medication Guideline - 2012 | PDF",1791843924]